UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 247

Sortiert nach

Tumor-Treating Fields: A Fourth Modality in Cancer Treatment

Clinical cancer research, 2018-01, Vol.24 (2), p.266-275

2018

Link zum Volltext

Verfügbarkeit prüfen

Breast Cancer Immunotherapy: Facts and Hopes

Clinical cancer research, 2018-02, Vol.24 (3), p.511-520

Emens, Leisha A

2018

Link zum Volltext

Verfügbarkeit prüfen

Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab

Clinical cancer research, 2015-12, Vol.21 (24), p.5453-5459

2015

Link zum Volltext

Verfügbarkeit prüfen

Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy

Clinical cancer research, 2011-07, Vol.17 (13), p.4550-4557

2011

Link zum Volltext

Verfügbarkeit prüfen

Tumor-Infiltrating Lymphocyte Therapy in Melanoma: Facts to the Future

Clinical cancer research, 2023-05, Vol.29 (10), p.1835-1854

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors

Clinical cancer research, 2018-03, Vol.24 (6), p.1287-1295

2018

Link zum Volltext

Verfügbarkeit prüfen

Effects of Co-occurring Genomic Alterations on Outcomes in Patients with KRAS -Mutant Non-Small Cell Lung Cancer

Clinical cancer research, 2018-01, Vol.24 (2), p.334-340

2018

Link zum Volltext

Verfügbarkeit prüfen

Dendritic Cell-Based Immunotherapy: State of the Art and Beyond

Clinical cancer research, 2016-04, Vol.22 (8), p.1897-1906

2016

Link zum Volltext

Verfügbarkeit prüfen

Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors

Clinical cancer research, 2016-03, Vol.22 (6), p.1364-1370

2016

Link zum Volltext

Verfügbarkeit prüfen

FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-cell Lymphoma

Clinical cancer research, 2019-03, Vol.25 (6), p.1702-1708

2019

Link zum Volltext

Verfügbarkeit prüfen

The Evolving Modern Management of Brain Metastasis

Clinical cancer research, 2019-11, Vol.25 (22), p.6570-6580

2019

Link zum Volltext

Verfügbarkeit prüfen

Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen

Clinical cancer research, 2016-08, Vol.22 (15), p.3734-3745

2016

Link zum Volltext

Verfügbarkeit prüfen

A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy (RT) Benefit and Assess Recurrence Risk

Clinical cancer research, 2018-12, Vol.24 (23), p.5895-5901

2018

Link zum Volltext

Verfügbarkeit prüfen

Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas

Clinical cancer research, 2017-01, Vol.23 (1), p.124-136

2017

Link zum Volltext

Verfügbarkeit prüfen

Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials

Clinical cancer research, 2018-04, Vol.24 (8), p.1824-1833

2018

Link zum Volltext

Verfügbarkeit prüfen

First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors

Clinical cancer research, 2015-09, Vol.21 (17), p.3870-3878

2015

Link zum Volltext

Verfügbarkeit prüfen

Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune-Checkpoint Blockade

Clinical cancer research, 2019-03, Vol.25 (5), p.1612-1623

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 Trial

Clinical cancer research, 2021-05, Vol.27 (10), p.2890-2898

2021

Link zum Volltext

Verfügbarkeit prüfen

Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer

Clinical cancer research, 2018-06, Vol.24 (11), p.2493-2504

2018

Link zum Volltext

Verfügbarkeit prüfen

Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells

Clinical cancer research, 2017-03, Vol.23 (6), p.1388-1396

2017

Link zum Volltext

Verfügbarkeit prüfen

A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer

Clinical cancer research, 2021-05, Vol.27 (9), p.2470-2480

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced Cancer

Clinical cancer research, 2018-04, Vol.24 (8), p.1816-1823

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with HER-2-Negative Metastatic Breast Cancer

Clinical cancer research, 2017-09, Vol.23 (18), p.5358-5365

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 247

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieClinical Cancer Research

ThemaTreatment Outcome

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(247)
Mit Volltextzugriff
(245)

Publikationsform

Artikel
(247)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(229)
Combined Modality Therapy
(228)
Life Sciences & Biomedicine
(227)
Oncology
(227)
Science & Technology
(227)
Female
(179)
Middle Aged
(158)
Male
(147)
Aged
(142)
Adult
(116)
Biological And Medical Sciences
(116)
Medical Sciences
(116)
Pharmacology. Drug Treatments
(110)
Antineoplastic Agents
(109)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(71)
Neoplasm Staging
(64)
Animals
(56)
Tumors
(55)
Aged, 80 And Over
(54)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

Zeitschrift / Serie

Clin Cancer Res
(1)

Menü

Weitere Dienste

Einstellungen

Tumor-Treating Fields: A Fourth Modality in Cancer Treatment

Breast Cancer Immunotherapy: Facts and Hopes

Mismatch Repair-Deficient Rectal Cancer and Resistance to Neoadjuvant Chemotherapy

Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab

Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy

Tumor-Infiltrating Lymphocyte Therapy in Melanoma: Facts to the Future

Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors

Effects of Co-occurring Genomic Alterations on Outcomes in Patients with KRAS -Mutant Non-Small Cell Lung Cancer

Dendritic Cell-Based Immunotherapy: State of the Art and Beyond

Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors

FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-cell Lymphoma

The Evolving Modern Management of Brain Metastasis

Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen

A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy (RT) Benefit and Assess Recurrence Risk

Combination Therapy with Anti-PD-1, Anti-TIM-3, and Focal Radiation Results in Regression of Murine Gliomas

Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG

Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials

First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors

Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune-Checkpoint Blockade

Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 Trial

Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer

Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells

A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer

Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced Cancer

Phase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with HER-2-Negative Metastatic Breast Cancer

Aktive Filter

Suchergebnisse filtern